G GROVE PHARMACEUTICALS Trademark

Trademark Overview

On Monday, November 21, 2016, a trademark application was filed for G GROVE PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the G GROVE PHARMACEUTICALS trademark a serial number of 87243457. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, December 31, 2024. This trademark is owned by Noven Therapeutics, LLC. The G GROVE PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, transdermal and transmucosal delivery systems in the nature of patches for the treatment of hormonal imbalances and deficiencies, and osteoporosis as well as women's hormonal or reproductive disorders, ailments and conditions; for the treatment of disorders of the central nervous system; for hormone therapy containing at least one estrogen or at least one progestogen
g grove pharmaceuticals

General Information

Serial Number87243457
Word MarkG GROVE PHARMACEUTICALS
Filing DateMonday, November 21, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, December 31, 2024
Registration Number5822190
Registration DateTuesday, July 30, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 7, 2017

Trademark Statements

Description of MarkThe mark consists of Capital "G" letter in white within a black circle followed by the words "Grove Pharmaceuticals" in black.
Goods and ServicesPharmaceutical preparations, namely, transdermal and transmucosal delivery systems in the nature of patches for the treatment of hormonal imbalances and deficiencies, and osteoporosis as well as women's hormonal or reproductive disorders, ailments and conditions; for the treatment of disorders of the central nervous system; for hormone therapy containing at least one estrogen or at least one progestogen
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 29, 2016
Primary Code005
First Use Anywhere DateFriday, November 2, 2018
First Use In Commerce DateFriday, November 2, 2018

Trademark Owner History

Party NameNoven Therapeutics, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressMiami, FL 33186
Party NameNoven Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMiami, FL 33186
Party NameNoven Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMiami, FL 33186

Trademark Events

Event DateEvent Description
Thursday, November 24, 2016NEW APPLICATION ENTERED
Tuesday, November 29, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 30, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, February 27, 2017ASSIGNED TO EXAMINER
Monday, March 6, 2017NON-FINAL ACTION WRITTEN
Monday, March 6, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 6, 2017NON-FINAL ACTION E-MAILED
Thursday, August 31, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 31, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 19, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, October 1, 2017ASSIGNED TO LIE
Wednesday, October 18, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 7, 2017PUBLISHED FOR OPPOSITION
Tuesday, November 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 2, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 1, 2018SOU TEAS EXTENSION RECEIVED
Friday, June 1, 2018SOU EXTENSION 1 FILED
Friday, June 1, 2018SOU EXTENSION 1 GRANTED
Tuesday, June 5, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 17, 2018SOU TEAS EXTENSION RECEIVED
Monday, December 17, 2018SOU EXTENSION 2 FILED
Monday, December 17, 2018SOU EXTENSION 2 GRANTED
Wednesday, December 19, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 13, 2019TEAS STATEMENT OF USE RECEIVED
Thursday, June 13, 2019SOU TEAS EXTENSION RECEIVED
Thursday, June 13, 2019SOU EXTENSION 3 FILED
Thursday, June 13, 2019USE AMENDMENT FILED
Monday, June 17, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 17, 2019SOU EXTENSION 3 GRANTED
Monday, June 17, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 25, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 26, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 30, 2019REGISTERED-PRINCIPAL REGISTER
Monday, February 3, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 3, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 30, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 30, 2024TEAS SECTION 8 & 15 RECEIVED
Monday, December 30, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, December 31, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, December 31, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

pharmaceuticals grove treatment hormonal least disorders ailments central conditions nervous system estrogen